China Cell Therapy Raw Materials Market Size & Outlook
China cell therapy raw materials market, 2018-2030 (US$M)
Related Markets
China cell therapy raw materials market highlights
- The China cell therapy raw materials market generated a revenue of USD 271.9 million in 2023 and is expected to reach USD 1,416.0 million by 2030.
- The China market is expected to grow at a CAGR of 26.6% from 2024 to 2030.
- In terms of segment, media was the largest revenue generating product in 2023.
- Antibodies is the most lucrative product segment registering the fastest growth during the forecast period.
Cell therapy raw materials market data book summary
| Market revenue in 2023 | USD 271.9 million |
| Market revenue in 2030 | USD 1,416.0 million |
| Growth rate | 26.6% (CAGR from 2023 to 2030) |
| Largest segment | Media |
| Fastest growing segment | Antibodies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Media, Sera, Cell Culture Supplements, Antibodies, Reagents & Buffers |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Danaher Corp, Sartorius AG, Stemcell Holdings Inc Ordinary Shares, Grifols SA Ordinary Shares - Class A, Charles River Laboratories International Inc, Actylis, ACROBiosystems, RoosterBio, PromoCell GmbH |
Other key industry trends
- In terms of revenue, China accounted for 6.4% of the global cell therapy raw materials market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China cell therapy raw materials market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,416.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Therapy Raw Materials Market Scope
Cell Therapy Raw Materials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China cell therapy raw materials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell therapy raw materials market will help companies and investors design strategic landscapes.
Media was the largest segment with a revenue share of 24.86% in 2023. Horizon Databook has segmented the China cell therapy raw materials market based on media, sera, cell culture supplements, antibodies, reagents & buffers covering the revenue growth of each sub-segment from 2018 to 2030.
- China Cell Therapy Raw Materials Product Outlook (Revenue, USD Million, 2018-2030)
- Media
- Sera
- Cell Culture Supplements
- Antibodies
- Reagents & Buffers
- Others
- China Cell Therapy Raw Materials End Use Outlook (Revenue, USD Million, 2018-2030)
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Others
Reasons to subscribe to China cell therapy raw materials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China cell therapy raw materials market databook
-
Our clientele includes a mix of cell therapy raw materials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China cell therapy raw materials market , including forecasts for subscribers. This country databook contains high-level insights into China cell therapy raw materials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China cell therapy raw materials market size, by product, 2018-2030 (US$M)
China Cell Therapy Raw Materials Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
